I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy and safety of adding an agent to bevacizumab/taxan..:
Liu XQ
;
Liu XD
;
Qiao TK
..
https://www.dovepress.com/efficacy-and-safety-of-adding-an-agent-to-bevacizumabtaxane-regimens-f-peer-reviewed-article-OTT. , 2016
Link:
https://doaj.org/article/d59296bdec4243ee8cb907a8e7775..
RT Journal T1 <Title>Efficacy and safety of adding an agent to bevacizumab/taxane regimens for the first-line treatment of Her2-negative patients with locally recurrent or metastatic breast cancer: results from seven randomized controlled trials</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:d59296bdec4243ee8cb907a8e7775323&Exemplar=1&LAN=DE A1 Liu XQ A1 Liu XD A1 Qiao TK A1 Chen W A1 Yuan SJ PB Dove Medical Press YR 2016 K1 Bevacizumab K1 Paclitaxel K1 Docetaxel K1 Breast cancer K1 Meta analysis K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.dovepress.com/efficacy-and-safety-of-adding-an-agent-to-bevacizumabtaxane-regimens-f-peer-reviewed-article-OTT LK http://dx.doi.org/https://doaj.org/article/d59296bdec4243ee8cb907a8e7775323 DO https://doaj.org/article/d59296bdec4243ee8cb907a8e7775323 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
